Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Jump to section
Related Articles
Cited By...
- Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia
- Small-Area Variation in the Care of Low-Risk Neonates in Massachusetts and Texas
- Neonatal Indirect Hyperbilirubinemia
- Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?
- Variation in Care and Clinical Outcomes Among Infants Hospitalized With Hyperbilirubinemia
- Case 1: Rapidly Rising Bilirubin Level in a 3-day-old Term Infant
- Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study
- Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening
- Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions
- Supporting Breastfeeding in Infants Hospitalized for Jaundice
- Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort
- Pathogenesis and Management of Indirect Hyperbilirubinemia in Preterm Neonates Less Than 35 Weeks: Moving Toward a Standardized Approach
- Providing Care for Infants Born at Home
- Evidence-Based Updates on the First Week of Exclusive Breastfeeding Among Infants >=35 Weeks
- Prevalence of and mothers knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study
- Prediction of Rebound Hyperbilirubinemia
- Legal Briefs: Multiple Missteps and System Failures Cause Kernicterus in 2 Infants
- Case 1: Severe Jaundice in a 2-day-old Term Neonate
- Potential protective effects of bilirubin following the treatment of neonatal hypoxic-ischemic encephalopathy with hypothermia therapy
- A Novel Icterometer for Hyperbilirubinemia Screening in Low-Resource Settings
- Congenital Syphilis: A Challenging Case for NICU Clinicians
- Screening and treatment to reduce severe hyperbilirubinaemia in infants in primary care (STARSHIP): a factorial stepped-wedge cluster randomised controlled trial protocol
- Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care
- Exposure to Phototherapy and Childhood Seizure Risk
- Wireless, battery-free, flexible, miniaturized dosimeters monitor exposure to solar radiation and to light for phototherapy
- The Snowball Effect of Low-Value Care
- How to evaluate diagnosis and management of biliary atresia in the era of liver Transplantation in China
- Adherence to AAP Healthy Newborn Discharge Criteria in a Tertiary Care Childrens Hospital
- Hyperbilirubinemia, Phototherapy, and Childhood Asthma
- Outcomes of neonatal jaundice in Taiwan
- Childhood Seizures After Phototherapy
- Phototherapy and Seizures: Should We Change Practice?
- Beyond "Asian": Specific East and Southeast Asian Races or Ethnicities Associated With Jaundice Readmission
- Neonatal Jaundice: Improved Quality and Cost Savings After Implementation of a Standard Pathway
- Neonatal Hyperbilirubinemia and Chronic Auditory Toxicity
- Burden of severe neonatal jaundice: a systematic review and meta-analysis
- Jaundice: Newborn to Age 2 Months
- Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia
- Use of a Smartphone App to Assess Neonatal Jaundice
- Re: Changs Score Is Only Helpful Within the First 4 to 5 Days of Life
- Current Scope of Practice for Newborn Care in Non-Intensive Hospital Settings
- A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy
- We Can Teach How to Bend the Cost Curve: Lessons in Pediatric High-Value Health Care
- Can I Stop Phototherapy for This Baby?
- Update on Pediatric Overuse
- Transcutaneous Bilirubinometry in Jaundiced Neonates: A Randomized Controlled Trial
- Hereditary Spherocytosis
- Phototherapy and Risk of Type 1 Diabetes
- The Bilirubin Binding Panel: A Henderson-Hasselbalch Approach to Neonatal Hyperbilirubinemia
- Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
- Battery-free, stretchable optoelectronic systems for wireless optical characterization of the skin
- Evaluating Nursery Phototherapy Use and Discharge Practices After the Creation of a Weekend Newborn Clinic
- Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California
- Neonatal Phototherapy and Infantile Cancer
- Utility of Decision Rules for Transcutaneous Bilirubin Measurements
- When Intensive Care Is Too Intense: Variations in Standard Practices Across Hospital Acuity Levels
- Benefits of Delayed Cord Clamping in Red Blood Cell Alloimmunization
- The Blockade of NF-{kappa}B Activation by a Specific Inhibitory Peptide Has a Strong Neuroprotective Role in a Sprague-Dawley Rat Kernicterus Model
- Predicting Nonhemolytic Neonatal Hyperbilirubinemia
- Topics in Neonatal Informatics: Essential Functionalities of the Neonatal Electronic Health Record
- Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn
- A Model for Predicting Significant Hyperbilirubinemia in Neonates From China
- Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds
- How to use: the direct antiglobulin test in newborns
- A Pediatrician's Practical Guide to Diagnosing and Treating Hereditary Spherocytosis in Neonates
- Medical Evaluation of Abandoned Infants Less Than 61 Days of Age
- Early Weight Loss Nomograms for Formula Fed Newborns
- Hospital Stay for Healthy Term Newborn Infants